摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methyl-2-(m-tolyl)oxazol-4(5H)-one | 1393357-22-6

中文名称
——
中文别名
——
英文名称
5-methyl-2-(m-tolyl)oxazol-4(5H)-one
英文别名
5-Methyl-2-(3-methylphenyl)-1,3-oxazol-4-one
5-methyl-2-(m-tolyl)oxazol-4(5H)-one化学式
CAS
1393357-22-6
化学式
C11H11NO2
mdl
——
分子量
189.214
InChiKey
PWEXWUXYVPUWIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    5-methyl-2-(m-tolyl)oxazol-4(5H)-one 在 4-chloro-N,N'-bis-[(S)-4-methyloxazolin-2-yl]pyridine 、 titanium(IV) isopropylate噻吩-2-甲酸亚铜(I)copper(I) trifluoromethanesulfonate benzene 作用下, 以 甲苯 为溶剂, 反应 49.5h, 生成 C27H24N4O4S
    参考文献:
    名称:
    Cu / Zn和Cu ​​/ Ti催化实现5H-噻唑-4-酮和5H-恶唑-4-酮的非对映和对映选择性炔丙基化
    摘要:
    报道为5不对称炔丙基取代(APS)反应ħ使用铜/锌双金属催化体系和5中的APS反应-噻唑-4-酮ħ使用Cu / Ti的催化体系-恶唑-4-酮。这些反应提供了具有两个邻位立体中心的高功能基团,末端炔烃含量高的产品,并具有良好至优异的非对映和对映选择性。这项研究表明,使用双金属催化体系作为一种可行的方法来改善铜催化的APS反应的选择性。
    DOI:
    10.1002/anie.201809391
  • 作为产物:
    描述:
    参考文献:
    名称:
    双核锌配合物催化的α-烷基-α-羟基羧酸衍生物的高立体选择性合成
    摘要:
    双核锌-ProPhenol催化剂可与作为亲核底物的恶唑-4(5 H)-酮进行高度对映选择性的硝基-迈克尔反应(请参阅方案,Nap = 2-萘基)。这项工作突出了ProPhenol配体家族的实用性。这些配体的模块性质被证明对于优化反应条件以实现出色的立体选择性至关重要。
    DOI:
    10.1002/anie.201201116
点击查看最新优质反应信息

文献信息

  • Highly enantioselective allylic alkylation of 5 H -oxazol-4-ones with Morita-Baylis-Hillman carbonates
    作者:Han Xu、Feng Sha、Xin-Yan Wu
    DOI:10.1016/j.tet.2018.06.055
    日期:2018.8
    An organocatalytic enantioselective allylic alkylation of 5H-oxazol-4-ones with Morita-Baylis-Hillman carbonates has been developed. With 10 mol% of commercially available cinchonidine, a wide range of substituted 5H-oxazol-4-one derivatives were constructed in good-to-excellent yields with high diastereo- and enantioselectivities. The allylic alkylation adducts obtained are valuable precursors for
    已经开发了用Morita-Baylis-Hillman碳酸盐对5 H-恶唑-4-酮进行有机催化对映选择性烯丙基烷基化反应。用10 mol%的市售可可宁定,以良好至优异的产率以及高的非对映选择性和对映选择性,构建了范围广泛的取代的5 H-恶唑-4-酮衍生物。获得的烯丙基烷基化加合物是用于合成手性α-烷基α-羟基羧酸生物的有价值的前体,其代表许多生物活性化合物中的一系列通用结构单元。
  • Chemoselective Switch in the Asymmetric Organocatalysis of 5<i>H</i>-Oxazol-4-ones and<i>N</i>-Itaconimides: Addition-Protonation or [4+2] Cycloaddition
    作者:Bo Zhu、Richmond Lee、Jiangtao Li、Xinyi Ye、San-Ni Hong、Shuai Qiu、Michelle L. Coote、Zhiyong Jiang
    DOI:10.1002/anie.201507796
    日期:2016.1.22
    We report a synthetic strategy for a chemoselective switch and a diastereo‐divergent approach for the asymmetric reaction of 5H‐oxazol‐4‐ones and N‐itaconimides catalyzed by l‐tert‐leucine‐derived tertiary amine–urea compounds. The reaction was modulated to harness either tandem conjugate addition–protonation or [4+2] cycloaddition as major product with excellent enantio‐ and diastereoselectivities
    我们报告的化学选择性开关和用于5不对称反应中的非对映发散方法合成策略ħ -恶唑-4-酮和Ñ -itaconimides催化升-叔亮酸衍生的叔胺-尿素化合物。调节反应以利用串联共轭加成-质子化或[4 + 2]环加成为主要产物,具有出色的对映异构和非对映异构选择性。将对映体富集的环加成产物置于碱性硅胶试剂中,与在加成质子化条件下直接获得的产物相比,可生成非对映异构体,从而开辟了非对映异构路线,从而形成了1,3-叔-叔-季盐立体中心。量子化学研究进一步为[4 + 2]过程提供了立体化学分析,并提出了这种化学选择性开关的合理机制。
  • Highly Enantio- and Diastereoselective [4 + 2] Cycloaddition of 5<i>H</i>-oxazol-4-ones with <i>N</i>-Maleimides
    作者:Shuai Qiu、Richmond Lee、Bo Zhu、Michelle L. Coote、Xiaowei Zhao、Zhiyong Jiang
    DOI:10.1021/acs.joc.6b01451
    日期:2016.9.2
    An organocatalytic asymmetric reaction between 5H-oxazol-4-ones and N-substituted maleimides is disclosed. Employing Takemoto's chiral tertiary amine-thiourea as the catalyst, [4 + 2] annulation reactions were performed with high chemoselectivity, leading to a series of biologically important chiral oxo-bridged piperidone-fused succinimides in good to excellent enantioselectivities (up to >99% ee) and >19:1 dr.
  • Organocatalytic Asymmetric Michael Addition of 5<i>H</i>-Oxazol-4-ones to Nitroolefins
    作者:Baokun Qiao、Yongqiang An、Qian Liu、Wenguo Yang、Hongjun Liu、Juan Shen、Lin Yan、Zhiyong Jiang
    DOI:10.1021/ol401062z
    日期:2013.5.17
    The first organocatalytic asymmetric Michael addition of 5H-oxazol-4-ones to nitroolefins has been developed. In the presence of easily prepared L-tert-leucine-derived tertiary amine/thiourea catalyst, the Michael addition of 5H-oxazol-4-ones to nitroolefins proceeded in an excellent diastereo- and enantioselective manner (up to 99% ee and >19:1 dr). The Michael adducts obtained are valuable precursors for the synthesis of chiral alpha-alkyl-alpha-hydroxy carboxylic acid derivatives, which represent a series of versatile building blocks in many biologically active compounds.
  • Highly enantioselective α-sulfenylation of 5H-oxazol-4-ones to N-(sulfanyl)succinimides
    作者:Mei Xu、Baokun Qiao、Shaobo Duan、Hongjun Liu、Zhiyong Jiang
    DOI:10.1016/j.tet.2014.09.037
    日期:2014.11
    An unprecedented asymmetric alpha-sulfenylation of 5H-oxazol-4-ones to N-(sulfanyl)succinimides has been established, to access various alpha-sulfenylated adducts with good to excellent enantioselectivities (86-95% ee) by utilizing a cinchona alkaloid-derived squaramide as catalyst. The conditions of this alpha-sulfenylation protocol simultaneously satisfy N-(arylthio)succinimides, N-(benzylthio)succinimides, and N-(alkylthio)succinimides by tuning the substituted groups of 5H-oxazol-4-ones on the 2-position as well as additives. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫